The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta. Paolicelli D, Iannazzo S, Santoni L, D'Onghia M, Direnzo V, Iaffaldano A, Puma E, Di Lecce V, Trojano M Value Health. 2015 Nov; 18(7):A754. Epub 2015 Oct 20. PMID: 26534225. Abstract CommentRecommendBookmarkWatch